Abstract: Disclosed are a linear vibration motor structure with a long service life, comprising a lower bracket, wherein a stator assembly is connected above the lower bracket; a vibrator assembly is sheathed outside the stator assembly; a casing is sheathed outside the vibrator assembly; the casing is connected above the lower bracket; the vibrator assembly is connected to the casing and the lower bracket by means of magnetic springs; and each magnetic spring comprises several first magnets and several third magnets. An implementation method for a linear vibration motor structure with a long service life is further disclosed.

Abstract: Disclosed is a fast response linear vibration motor structure, comprising a lower bracket; an FPC is connected above the lower bracket, a stator assembly is disposed above the FPC, an outer sleeve of the stator assembly is provided with a vibrator assembly, an outer sleeve of the vibrator assembly is provided with a housing, the housing is connected above the lower bracket, the vibrator assembly is connected to the housing by means of elastic pieces, two sets of coils are wound on a core, and the coils are electrically connected to the FPC. The vibrator assembly comprises a magnetic steel group and a second mass block, wherein the magnetic steel group is embedded inside of the second mass block. Further disclosed is an implementation method for a fast response linear vibration motor structure.

Abstract: The present invention relates to a drop pill for treating coronary heart disease, comprising an active pharmaceutical ingredient (API), a matrix adjuvant, a plastifying adjuvant, propylene glycol and water. the API is prepared from Radix salvia miltiorrhira, Panax notoginseng and Borneol; the matrix adjuvant is erythritol; the plastifying adjuvant is one or more selected from the group consisting of polyethylene glycols, xylitol, lactitol, mannitol, glycerine, soluble amylum, gelatin, methyl cellulose, sodium carboxymethycellulose (CMC-Na), hydroxypropyl methylcellulose (HPMC), arabic gum, alginic acid, dextrin, cyclodextrin (CD), citrate, glycerol acetate, dibutyl sebacate, refined coconut oil and castor oil; Wherein, relative to the total weight of the drop pill, the API is 1˜40 wt %, the plastifying adjuvant 0˜10 wt %, the propylene glycol 1˜10 wt %, the water 0˜10 wt % and the balance is the matrix adjuvant.